Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment

Japan has a nationwide mass-screening program for neuroblastoma in 6-month-old infants. Neuroblastoma can regress spontaneously, and some institutions observe selected cases. We evaluated the management of screened neuroblastoma at our hospital since 1997 when an observation program was introduced....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric surgery international 2004-01, Vol.20 (1), p.27-32
Hauptverfasser: Okazaki, Tadaharu, Kohno, Sumio, Mimaya, Jun-ichi, Hasegawa, Shiro, Urushihara, Naoto, Yoshida, Atsushi, Kawano, Shinya, Kusafuka, Junichi, Horikoshi, Yasuo, Takashima, Yoshifumi, Aoki, Katsuhiko, Hamazaki, Minoru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Japan has a nationwide mass-screening program for neuroblastoma in 6-month-old infants. Neuroblastoma can regress spontaneously, and some institutions observe selected cases. We evaluated the management of screened neuroblastoma at our hospital since 1997 when an observation program was introduced. Criteria for the observation program were stage-I, stage-II, or stage-IVs tumors, urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) levels
ISSN:0179-0358
1437-9813
DOI:10.1007/s00383-003-1070-x